C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.740
+0.240 (6.86%)
At close: Jan 14, 2025, 4:00 PM
3.690
-0.050 (-1.34%)
After-hours: Jan 14, 2025, 6:09 PM EST
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $264.00 million as of January 14, 2025. Its market cap has increased by 4.43% in one year.
Market Cap
264.00M
Enterprise Value
44.58M
1-Year Change
4.43%
Ranking
Category
Stock Price
$3.74
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $264.00M, a decrease of -65.83%. That is a compound annual growth rate of -22.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2025 | 247.06M | -2.78% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | 1.43B | 84.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 722.33B |
| UnitedHealth Group | 500.17B |
| Novo Nordisk | 385.14B |
| Johnson & Johnson | 347.37B |
| AbbVie | 312.89B |
| Merck & Co. | 254.76B |
| Thermo Fisher Scientific | 213.05B |
| AstraZeneca | 207.72B |